 When cells sickle they can cause recurrent episodes of acute pain that often require hospitalization, transfusions, and strong pain medication.There is no cure.In the early 1980s a team led by Charache began testing a few patients at Hopkins to see if hydroxyurea, a cancer drug, would help to abate the symptoms of the disease.